You are here

News and Events

For an overview of the latest news, press releases and blog posts from Cancer Research UK visit the Cancer News page.

Below you will find the latest press releases, news and event information from the Cancer Research UK Commercial Partnerships team and our legal entity, Cancer Research Technology (CRT).

Date1	Press Release
12 January 2016	FORMA Therapeutics and CRT form a third virtual company to advance deubiquitination assets	Read more
6 January 2016	Cancer Research Technology, Cell Therapy Catapult and University of Birmingham launch new collaboration for CAR-T cell immuno-oncology therapy development	Read more
9 December 2015	Cancer Research Technology appoints Deborah Harland as Non-Executive Director	Read more
7 December 2015	Nemucore Medical Innovations options clinical-stage Aurora Kinase Inhibitor GSK1070916 from CRT	Read more
11 September 2015	Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge	Read more
9 July 2015	Cancer Research UK and Cancer Research Technology announce partnership with Monopar Therapeutics to develop new oncology compound	Read more
18 May 2015	R&D alliance restructure presents new DNA damage response partnership opportunities including leading PolQ project	Read more
13 April 2015	Cancer Research Technology and Medivir collaborate to develop new class of cancer drugs	Read more
1 April 2015	Consortium signs deal with Basilea to develop resistance-busting cancer drugs	Read more
30 March 2015	CRT and BioInvent expand collaboration with University of Southampton scientists to develop new immunotherapy treatments for cancer	Read more

Pages

Date	Other news
15 December 2011	FEATURE: CCR4 - from target discovery to a license and sponsored collaboration with Affitech
15 December 2011	FEATURE: CRT reflects on a successful NCRI conference
1 September 2011	CRT's Discovery Laboratory Autotaxin programme progresses to Lead Optimisation
19 August 2011	Preclinical Development Candidate selected for Chk1 Inhibitor Programme
28 July 2011	FEATURE: Abiraterone receives approval from FDA to be marketed as a prostate cancer therapy - Zytiga
28 July 2011	FEATURE: BliNK Therapeutics, our 24th spin-out company is formed
28 July 2011	FEATURE: CRT pioneers new ways of generating exciting research and licensing discoveries
25 May 2011	New Type of Hormone Therapy Extends Prostate Cancer Patients' Lives, Study Finds
21 March 2011	Positive Results in Genentech Ph II Clinical Trial of GDC-0449 in Advanced Basal Cell Carcinoma
10 March 2011	Biothera acquires MUC1 anti-cancer monoclonal antibody from Antisoma

Pages